CoChat

Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center

Open access

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index; 15 of the 29 sources its claims cite were checked for support.

Abstract

The purpose of this study was to assess the clinical impact of the BioFire FilmArray Meningitis/Encephalitis (ME) panel on antimicrobial use and clinical outcomes. This retrospective, quasi-experiment evaluated adult and pediatric patients with suspected ME, evidenced by cerebrospinal fluid (CSF) culture. Hospital-acquired meningitis patients and patients who received antimicrobials >48 h prior to lumbar puncture were excluded. The primary endpoint was days of antimicrobial therapy pre- and post-implementation of the ME panel. Secondary endpoints included total length of stay, 30-day readmission, and individual days of antimicrobial therapy. Two hundred and sixty-four total adult and pediatric patients were included. Antimicrobial days of therapy had a median of 3 days (IQR 0−5) in the pre vs. post group with a median of 2 days (2−5) (p = 0.099). Days of therapy for acyclovir were significantly decreased in the post group (median 2 days [IQR 1−3] vs. 3 days [IQR 2.5−4.5], p = 0.0002). There were no significant differences in the secondary endpoints. Overall, implementation of the ME panel impacted the duration of antimicrobials, particularly acyclovir; however, opportunities for further education regarding antimicrobial de-escalation and utilization of the panel were identified. Antimicrobial stewardship program intervention is critical to maximize benefit of this rapid diagnostic test.

Overview

CoChat Summary

TL;DR

In this retrospective pre-post study at a 722-bed academic medical center, implementation of the BioFire FilmArray ME panel did not significantly change overall antimicrobial days of therapy or clinical outcomes, but it did significantly reduce acyclovir duration. The authors conclude that the panel’s benefit likely depends on pairing it with antimicrobial stewardship or clinical guidance.

Key findings

  • A total of 264 patients were analyzed, 132 pre-implementation and 132 post-implementation.
  • Overall antimicrobial days of therapy were median 3 days [IQR 0–5] pre vs 2 days [IQR 2–5] post, which was not statistically significant (p = 0.099).
  • Acyclovir days of therapy were significantly shorter after implementation: median 3 days [IQR 2.5–4.5] pre vs 2 days [IQR 1–3] post (p = 0.0002).
  • Secondary outcomes were similar between groups: length of stay, 30-day readmission, and mortality showed no significant differences.
  • The ME panel detected a pathogen in 18/132 post-group patients (13.6%); detection was 2/132 (3.7%) in adults and 16/132 (20.5%) in pediatrics.

Methods

  • Design: Retrospective pre-post quasi-experiment with a 1-year washout period around ME panel implementation.
  • Sample/data: Patients with CSF culture results at UMMC, comparing 1 Aug 2013–1 Aug 2016 vs 1 Aug 2017–1 Aug 2020; excluded patients with antimicrobials >48 h before LP, polymicrobial CSF infection, healthcare-associated meningitis, and post-implementation patients without ME panel testing.
  • Analysis: Descriptive statistics plus Mann–Whitney U, Fisher’s exact, and chi-squared tests; primary endpoint was antimicrobial days of therapy (DOT).

Limitations

  • The paper states that 25% of patients received no antimicrobial therapy despite CSF diagnostic testing, and many were being evaluated for ocular or neurological diseases such as multiple sclerosis; this suggests possible overuse/inappropriate ordering of the panel.
  • The authors state the study was from a single center and that a larger, geographically broader sample would improve generalizability.
  • The authors also state interpretation is limited by the overall low positivity rate, especially in adults.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/diseases10040110

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Study Flow Diagram.
Figure 1 Study Flow Diagram.CC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 0 Not valid · 5 Not checked · 27 Own results and interpretations

9 more claims

Create a free account to see all 45 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Citations

Cites

Show all 18 references

Cited by

See all 22

Metadata

Authors
Markovich, K., Wingler, M. J. B., Stover, K. R., Barber, K. E., Wagner, J. L., & Cretella, D. A.
Affiliations
  • Steward Healthcare, Fall River, MA 02721, USA
  • University of Mississippi Medical Center (US)
  • University of Mississippi (US)
Corresponding author
Stover, Kayla R.
Venue
Diseases
Publisher
MDPI AG
Published
2022-11-20
Volume
10
Issue
4
Pages
110
ISSN
2079-9721 (ISSN-L)
OpenAlex
W4309656609
Cited by
22
References
18
Citations by year
2026: 5 · 2025: 7 · 2024: 7 · 2023: 3
FWCI
2.14
Type
journal article
Language
en
Open access
Locations
  • Diseases (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
Keywords
meningitis, encephalitis, antimicrobial stewardship, antibiotic de-escalation, acyclovir, antimicrobial duration, rapid diagnostic tests, cerebrospinal fluid culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center. https://app.cochat.ai/papers/10.3390/diseases10040110
The paper
Markovich, K., Wingler, M. J. B., Stover, K. R., Barber, K. E., Wagner, J. L., & Cretella, D. A. (2022). Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center. Diseases. https://doi.org/10.3390/diseases10040110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.